Schedule 13G ownership disclosure
Syndax Pharmaceuticals Inc
Security class unavailable · CUSIP: 87164F105
Event date: 2019-09-26
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 6.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-19-265254
- Form type
- SC 13G
- Filer
- Access Industries Holdings LLC
- CIK
- CIK 1391297
- Filed
- Oct 09, 2019
- Reporting period
- Sep 26, 2019
- Description
- Schedule 13G beneficial ownership